| Threshold Pharmaceuticals, Inc Patent applications |
| Patent application number | Title | Published |
|---|
| 20110251159 | Phosphoramidate Alkylator Prodrugs - Phosphoramidate alkylator prodrugs can be used to treat cancer when administered alone or in combination with one or more anti-neoplastic agents. | 10-13-2011 |
| 20110182909 | Glufosfamide combination therapy - Glufosfamide administered in combination with other chemotherapeutic agents is useful in cancer treatment. | 07-28-2011 |
| 20100183742 | PHOSPHORAMIDATE ALKYLATOR PRODRUGS FOR THE TREATMENT OF CANCER - Compositions containing, and, methods administering, TH302, are useful in treatment of cancer and other hyper-proliferative diseases. | 07-22-2010 |
| 20100104549 | GLUFOSFAMIDE COMBINATION THERAPY - The co-administration of glufosfamide and a glucose lowering drug other than insulin is efficacious in cancer treatment. | 04-29-2010 |
| 20090042820 | Tubulin Binding Anti Cancer Agents And Prodrugs Thereof - Novel tubulin binding compounds and hypoxia activated prodrugs of novel and known tubulin binding compounds useful for treating cancer and other hyperproliferative diseases are disclosed. | 02-12-2009 |
| 20080214576 | Topoisomerase Inhibitors and Prodrugs - Compositions and methods for treating cancer and other hyperproliferatice disease conditions with topoisomerase inhibitors and their prodrugs are disclosed. | 09-04-2008 |
